Document Detail


Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions.
MedLine Citation:
PMID:  17355166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Peripheral arterial occlusive disease (PAOD) of the lower extremities is becoming more prevalent worldwide. Nonsurgical treatment options provide the foundation for management. Lifestyle and risk factor modification should be emphasized in this patient population because of the associated adverse cardiovascular events. This includes implementation of a regular walking and smoking-cessation programs, aggressive control of hyperlipidemia, hypertension and diabetes mellitus, and treatment of hyperhomocysteinemia. Antiplatelet agents such as aspirin (acetylsalicylic acid) or clopidogrel are not specifically indicated for claudication but these drugs should be used in all patients with PAOD to prevent secondary ischemic events. Currently, cilostazol is the only US FDA approved agent that appears effective for the treatment of claudication symptoms. Several agents have been used with success outside of the US and others are still undergoing testing. Definitive recommendations cannot be made on the use of these drugs until further evaluation is completed. Ongoing research with new strategies for angiogenesis and the use of progenitor cells has yielded encouraging results, particularly for patients with critical limb ischemia and limited options. Advances in endovascular technology over the last several years have greatly enhanced the ability to diagnose and treat specific anatomic lesions that previously would have required open surgical correction. The use of percutaneous transluminal angioplasty and stents in the lower extremities has had considerable success when following specific guidelines such as those set forth by the TransAtlantic Inter-Society Consensus Working Group.
Authors:
Krishna Mannava; Samuel R Money
Related Documents :
19703746 - Feasibility and midterm outcomes of percutaneous transhepatic balloon angioplasty for s...
2524606 - Percutaneous transluminal angioplasty versus surgery for limb-threatening ischemia.
9393536 - Balloon dacryocystoplasty: indications and contraindications.
10735426 - External beam irradiation as an adjunctive treatment in failing dialysis shunts.
23088416 - Tenotomy versus tenodesis in the treatment of the long head of biceps brachii tendon le...
21105636 - A prospective study of the association between surgeon experience and short-term patien...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of cardiovascular drugs : drugs, devices, and other interventions     Volume:  7     ISSN:  1175-3277     ISO Abbreviation:  Am J Cardiovasc Drugs     Publication Date:  2007  
Date Detail:
Created Date:  2007-03-14     Completed Date:  2007-07-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100967755     Medline TA:  Am J Cardiovasc Drugs     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  59-66     Citation Subset:  IM    
Affiliation:
Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA. kmannava@ochsner.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Balloon / methods
Arterial Occlusive Diseases / therapy*
Humans
Lower Extremity / blood supply*
Physician's Practice Patterns / trends
Practice Guidelines as Topic
Stents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Next Document:  Current management of transient ischemic attack.